A non-interventional post-authorisation safety study to investigate drug utilisation and safety monitoring patterns for Lemtrada (alemtuzumab)

First published 26/08/2021

Last updated 19/09/2025

EU PAS number:

EUPAS42540

Study

Finalised

Documents

Study protocol

Initial protocol

alemtuzumab-lemtrada-dus-pass-protocol-may-2021_Redacted

English (1.77 MB - PDF) View document

Updated protocol

lemtrada-dus-pass-amended-protocol-V3.1-Final_clean version_12-Dec-2023_redacted.pdf

First published: 04/09/2024

English (2.12 MB - PDF) View document

Study results

alemtuzumab-lemtrada-dus(dut0008)final-report-abstract.pdf

English (804.97 KB - PDF) View document

Study report

Other information

Secondary tabs